3.6.0.2 html 335 465 1 false 113 0 false 9 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Non-Controlling Interest and Stockholders' Deficit Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfNonControllingInterestAndStockholdersDeficit Consolidated Statements of Non-Controlling Interest and Stockholders' Deficit Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Cash Flows Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100060 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPolicies Nature of the Business and Summary of Significant Accounting Policies Notes 7 false false R8.htm 100070 - Disclosure - Consolidated Subsidiaries Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureConsolidatedSubsidiaries Consolidated Subsidiaries Notes 8 false false R9.htm 100080 - Disclosure - Net Loss Per Common Share Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNetLossPerCommonShare Net Loss Per Common Share Notes 9 false false R10.htm 100090 - Disclosure - License and Collaboration Agreements Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureLicenseAndCollaborationAgreements License and Collaboration Agreements Notes 10 false false R11.htm 100100 - Disclosure - Product Revenue Reserves and Allowances Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureProductRevenueReservesAndAllowances Product Revenue Reserves and Allowances Notes 11 false false R12.htm 100110 - Disclosure - Fair Value of Financial Instruments Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 12 false false R13.htm 100120 - Disclosure - Marketable Securities Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 13 false false R14.htm 100130 - Disclosure - Inventory Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureInventory Inventory Notes 14 false false R15.htm 100140 - Disclosure - Goodwill and Intangible Assets, Net Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNet Goodwill and Intangible Assets, Net Notes 15 false false R16.htm 100150 - Disclosure - Property and Equipment, Net Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 16 false false R17.htm 100160 - Disclosure - Accounts Payable, Accrued Expenses and Other Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOther Accounts Payable, Accrued Expenses and Other Notes 17 false false R18.htm 100170 - Disclosure - Borrowings Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowings Borrowings Notes 18 false false R19.htm 100180 - Disclosure - Restructuring Activities Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRestructuringActivities Restructuring Activities Notes 19 false false R20.htm 100190 - Disclosure - Common Stock Warrants Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommonStockWarrants Common Stock Warrants Notes 20 false false R21.htm 100200 - Disclosure - Common Stock Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommonStock Common Stock Notes 21 false false R22.htm 100210 - Disclosure - Stock-Based Compensation Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 22 false false R23.htm 100220 - Disclosure - Income Taxes Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 23 false false R24.htm 100230 - Disclosure - Commitments and Contingencies Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 24 false false R25.htm 100240 - Disclosure - Related Party Transactions Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 25 false false R26.htm 100250 - Disclosure - Retirement Plan Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRetirementPlan Retirement Plan Notes 26 false false R27.htm 100260 - Disclosure - Selected Quarterly Financial Data (Unaudited) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataUnaudited Selected Quarterly Financial Data (Unaudited) Notes 27 false false R28.htm 100270 - Disclosure - Going Concern Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureGoingConcern Going Concern Notes 28 false false R29.htm 100280 - Disclosure - Subsequent Event Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureSubsequentEvent Subsequent Event Notes 29 false false R30.htm 100290 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies (Policies) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies Nature of the Business and Summary of Significant Accounting Policies (Policies) Policies http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPolicies 30 false false R31.htm 100300 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesTables Nature of the Business and Summary of Significant Accounting Policies (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPolicies 31 false false R32.htm 100310 - Disclosure - Net Loss Per Common Share (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNetLossPerCommonShareTables Net Loss Per Common Share (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNetLossPerCommonShare 32 false false R33.htm 100320 - Disclosure - License and Collaboration Agreements (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsTables License and Collaboration Agreements (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureLicenseAndCollaborationAgreements 33 false false R34.htm 100330 - Disclosure - Product Revenue Reserves and Allowances (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureProductRevenueReservesAndAllowancesTables Product Revenue Reserves and Allowances (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureProductRevenueReservesAndAllowances 34 false false R35.htm 100340 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureFairValueOfFinancialInstruments 35 false false R36.htm 100350 - Disclosure - Inventory (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureInventoryTables Inventory (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureInventory 36 false false R37.htm 100360 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNet 37 false false R38.htm 100370 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosurePropertyAndEquipmentNet 38 false false R39.htm 100380 - Disclosure - Accounts Payable, Accrued Expenses and Other (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOtherTables Accounts Payable, Accrued Expenses and Other (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOther 39 false false R40.htm 100390 - Disclosure - Borrowings (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowingsTables Borrowings (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowings 40 false false R41.htm 100400 - Disclosure - Restructuring Activities (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRestructuringActivitiesTables Restructuring Activities (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRestructuringActivities 41 false false R42.htm 100410 - Disclosure - Common Stock Warrants (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommonStockWarrantsTables Common Stock Warrants (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommonStockWarrants 42 false false R43.htm 100420 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureStockBasedCompensation 43 false false R44.htm 100430 - Disclosure - Income Taxes (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureIncomeTaxes 44 false false R45.htm 100440 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingencies 45 false false R46.htm 100450 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataUnauditedTables Selected Quarterly Financial Data (Unaudited) (Tables) Tables http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataUnaudited 46 false false R47.htm 100460 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Nature of the Business and Summary of Significant Accounting Policies - Additional Information (Detail) Details 47 false false R48.htm 100470 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment Including Leasehold Improvements (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentIncludingLeaseholdImprovementsDetail Nature of the Business and Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment Including Leasehold Improvements (Detail) Details 48 false false R49.htm 100480 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies - Schedules of Concentration of Risk by Risk Factor - Gross Sales Revenue (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesSchedulesOfConcentrationOfRiskByRiskFactorGrossSalesRevenueDetail Nature of the Business and Summary of Significant Accounting Policies - Schedules of Concentration of Risk by Risk Factor - Gross Sales Revenue (Detail) Details 49 false false R50.htm 100490 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies - Schedules of Concentration of Risk by Risk Factor - Gross Accounts Receivable (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesSchedulesOfConcentrationOfRiskByRiskFactorGrossAccountsReceivableDetail Nature of the Business and Summary of Significant Accounting Policies - Schedules of Concentration of Risk by Risk Factor - Gross Accounts Receivable (Detail) Details 50 false false R51.htm 100500 - Disclosure - Consolidated Subsidiaries - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureConsolidatedSubsidiariesAdditionalInformationDetail Consolidated Subsidiaries - Additional Information (Detail) Details 51 false false R52.htm 100510 - Disclosure - Net Loss Per Common Share - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail Net Loss Per Common Share - Additional Information (Detail) Details 52 false false R53.htm 100520 - Disclosure - Net Loss Per Common Share - Schedule of Securities Excluded from Computation of Diluted Loss Per Share (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfSecuritiesExcludedFromComputationOfDilutedLossPerShareDetail Net Loss Per Common Share - Schedule of Securities Excluded from Computation of Diluted Loss Per Share (Detail) Details 53 false false R54.htm 100530 - Disclosure - License and Collaboration Agreements - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsAdditionalInformationDetail License and Collaboration Agreements - Additional Information (Detail) Details 54 false false R55.htm 100540 - Disclosure - License and Collaboration Agreements - Schedule of Revenue Recognized and Assets and Liabilities under Collaborative Arrangements (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsScheduleOfRevenueRecognizedAndAssetsAndLiabilitiesUnderCollaborativeArrangementsDetail License and Collaboration Agreements - Schedule of Revenue Recognized and Assets and Liabilities under Collaborative Arrangements (Detail) Details 55 false false R56.htm 100560 - Disclosure - Product Revenue Reserves and Allowances - Summary of Product Revenue Reserve and Allowance Categories (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureProductRevenueReservesAndAllowancesSummaryOfProductRevenueReserveAndAllowanceCategoriesDetail Product Revenue Reserves and Allowances - Summary of Product Revenue Reserve and Allowance Categories (Detail) Details 56 false false R57.htm 100570 - Disclosure - Fair Value of Financial Instruments - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Fair Value of Financial Instruments - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) Details 57 false false R58.htm 100580 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail Fair Value of Financial Instruments - Additional Information (Detail) Details 58 false false R59.htm 100590 - Disclosure - Marketable Securities - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetail Marketable Securities - Additional Information (Detail) Details 59 false false R60.htm 100600 - Disclosure - Inventory - Schedule of Inventory (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureInventoryScheduleOfInventoryDetail Inventory - Schedule of Inventory (Detail) Details 60 false false R61.htm 100610 - Disclosure - Inventory - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureInventoryAdditionalInformationDetail Inventory - Additional Information (Detail) Details 61 false false R62.htm 100620 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNetAdditionalInformationDetail Goodwill and Intangible Assets, Net - Additional Information (Detail) Details 62 false false R63.htm 100630 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill and Intangible Assets (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNetScheduleOfGoodwillAndIntangibleAssetsDetail Goodwill and Intangible Assets, Net - Schedule of Goodwill and Intangible Assets (Detail) Details 63 false false R64.htm 100640 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Expected Future Amortization Expense for Intangible Assets for the Next Five-Year Period (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseForIntangibleAssetsForNextFiveYearPeriodDetail Goodwill and Intangible Assets, Net - Schedule of Expected Future Amortization Expense for Intangible Assets for the Next Five-Year Period (Detail) Details 64 false false R65.htm 100650 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) Details 65 false false R66.htm 100660 - Disclosure - Property and Equipment, Net - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail Property and Equipment, Net - Additional Information (Detail) Details 66 false false R67.htm 100670 - Disclosure - Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOtherScheduleOfAccountsPayableAccruedExpensesAndOtherDetail Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Details 67 false false R68.htm 100680 - Disclosure - Borrowings - 2022 Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowings2022NotesAdditionalInformationDetail Borrowings - 2022 Notes - Additional Information (Detail) Details 68 false false R69.htm 100690 - Disclosure - Borrowings - Convertible Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowingsConvertibleNotesAdditionalInformationDetail Borrowings - Convertible Notes - Additional Information (Detail) Details 69 false false R70.htm 100700 - Disclosure - Borrowings - Loan Agreement - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowingsLoanAgreementAdditionalInformationDetail Borrowings - Loan Agreement - Additional Information (Detail) Details 70 false false R71.htm 100710 - Disclosure - Borrowings - Credit Facility - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowingsCreditFacilityAdditionalInformationDetail Borrowings - Credit Facility - Additional Information (Detail) Details 71 false false R72.htm 100720 - Disclosure - Borrowings - Silver Creek Convertible Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowingsSilverCreekConvertibleNotesAdditionalInformationDetail Borrowings - Silver Creek Convertible Notes - Additional Information (Detail) Details 72 false false R73.htm 100730 - Disclosure - Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureBorrowingsScheduleOfFutureMinimumPaymentsUnderLoansPayableDetail Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Details 73 false false R74.htm 100740 - Disclosure - Restructuring Activities - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRestructuringActivitiesAdditionalInformationDetail Restructuring Activities - Additional Information (Detail) Details 74 false false R75.htm 100750 - Disclosure - Restructuring Activities - Summary of Charges Related to Restructuring Activities (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRestructuringActivitiesSummaryOfChargesRelatedToRestructuringActivitiesDetail Restructuring Activities - Summary of Charges Related to Restructuring Activities (Detail) Details 75 false false R76.htm 100760 - Disclosure - Common Stock Warrants - Schedule of Common Stock Warrant Activity of the Company (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommonStockWarrantsScheduleOfCommonStockWarrantActivityOfCompanyDetail Common Stock Warrants - Schedule of Common Stock Warrant Activity of the Company (Detail) Details 76 false false R77.htm 100770 - Disclosure - Common Stock Warrants - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformationDetail Common Stock Warrants - Additional Information (Detail) Details 77 false false R78.htm 100780 - Disclosure - Common Stock - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommonStockAdditionalInformationDetail Common Stock - Additional Information (Detail) Details 78 false false R79.htm 100790 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 79 false false R80.htm 100800 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToCalculateFairValueOfOptionsGrantedToEmployeesDetail Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees (Detail) Details 80 false false R81.htm 100810 - Disclosure - Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRecognizedStockBasedCompensationExpenseDetail Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Details 81 false false R82.htm 100820 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetail Stock-Based Compensation - Summary of Stock Option Activity (Detail) Details 82 false false R83.htm 100830 - Disclosure - Income Taxes - Schedule of Reconciliation of the Company's Effective Tax Rate to the Statutory Federal Income Tax Rate (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfCompanySEffectiveTaxRateToStatutoryFederalIncomeTaxRateDetail Income Taxes - Schedule of Reconciliation of the Company's Effective Tax Rate to the Statutory Federal Income Tax Rate (Detail) Details 83 false false R84.htm 100840 - Disclosure - Income Taxes - Schedule of Temporary Differences That Give Rise to Significant Net Deferred Tax Assets (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureIncomeTaxesScheduleOfTemporaryDifferencesThatGiveRiseToSignificantNetDeferredTaxAssetsDetail Income Taxes - Schedule of Temporary Differences That Give Rise to Significant Net Deferred Tax Assets (Detail) Details 84 false false R85.htm 100850 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 85 false false R86.htm 100860 - Disclosure - Income Taxes - Schedule of Changes in the Valuation Allowance (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangesInValuationAllowanceDetail Income Taxes - Schedule of Changes in the Valuation Allowance (Detail) Details 86 false false R87.htm 100870 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 87 false false R88.htm 100880 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetail Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Detail) Details 88 false false R89.htm 100890 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 89 false false R90.htm 100900 - Disclosure - Retirement Plan - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureRetirementPlanAdditionalInformationDetail Retirement Plan - Additional Information (Detail) Details 90 false false R91.htm 100910 - Disclosure - Selected Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataUnauditedScheduleOfQuarterlyFinancialInformationDetail Selected Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Information (Detail) Details http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataUnauditedTables 91 false false R92.htm 100920 - Disclosure - Going Concern - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureGoingConcernAdditionalInformationDetail Going Concern - Additional Information (Detail) Details 92 false false R93.htm 100930 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20161231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 93 false false All Reports Book All Reports mack-20161231.xml mack-20161231.xsd mack-20161231_cal.xml mack-20161231_def.xml mack-20161231_lab.xml mack-20161231_pre.xml true true